Nobivac L4

Authorised

This medicine is authorised for use in the European Union

canine leptospirosis vaccine (inactivated)

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Nobivac L4 : EPAR - Summary for the public

Product information

Nobivac L4 : EPAR - Product Information

Nobivac L4 : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Nobivac L4
• Active substance:
  • Leptospira interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000)
  • L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001)
  • L. interrogans serogroup Australis serovar Bratislava (strain As-05-073)
  • L. kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
• International non-proprietary name (INN) or common name:
  canine leptospirosis vaccine (inactivated)

Authorisation details

• EMA product number:
  EMEA/V/C/002010

Assessment history

Changes since initial authorisation of medicine

Nobivac L4 : EPAR - Procedural steps taken and scientific information after authorisation

CVMP post-authorisation summary of positive opinion for Nobivac L4 and Nobivac LoVo L4 (VRA0000184065)

Adopted Reference Number: EMADOC-1700519818-2188844

Initial marketing authorisation documents

Nobivac L4 : EPAR - Public assessment report

Adopted

CVMP summary of positive opinion for Nobivac L4

Adopted Reference Number: EMA/CVMP/282463/2012